Gross Margin - Prostatype Genomics AB (F:PGO) - Alpha Spread
P

Prostatype Genomics AB
F:PGO

Watchlist Manager
Prostatype Genomics AB
F:PGO
Watchlist
Price: 0.0012 EUR Market Closed
Market Cap: 1.2m EUR
Have any thoughts about
Prostatype Genomics AB?
Write Note

Gross Margin
Prostatype Genomics AB

402.3%
Current
313%
Average
63%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
402.3%
=
Gross Profit
4.1m
/
Revenue
1m

Gross Margin Across Competitors

Country SE
Market Cap 18.8m SEK
Gross Margin
402%
Country US
Market Cap 341.5B USD
Gross Margin
67%
Country US
Market Cap 180.5B USD
Gross Margin
63%
Country US
Market Cap 129B USD
Gross Margin
87%
Country US
Market Cap 123.6B USD
Gross Margin
86%
Country US
Market Cap 105B USD
Gross Margin
77%
Country US
Market Cap 94.1B EUR
Gross Margin
76%
Country AU
Market Cap 142.3B AUD
Gross Margin
52%
Country US
Market Cap 39.3B EUR
Gross Margin
75%
Country US
Market Cap 38.5B USD
Gross Margin
97%
Country US
Market Cap 35.2B USD
Gross Margin
87%

Profitability Report

View the profitability report to see the full profitability analysis for Prostatype Genomics AB.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
402.3%
=
Gross Profit
4.1m
/
Revenue
1m
What is the Gross Margin of Prostatype Genomics AB?

Based on Prostatype Genomics AB's most recent financial statements, the company has Gross Margin of 402.3%.